Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fuji
Julphar
AstraZeneca
Covington
Cantor Fitzgerald
US Department of Justice
Daiichi Sankyo
Baxter
Deloitte

Generated: June 18, 2018

DrugPatentWatch Database Preview

GEN-XENE Drug Profile

or, see our see our flat-rate plans

« Back to Dashboard

When do Gen-xene patents expire, and what generic alternatives are available?

Gen-xene is a drug marketed by Alra and is included in three NDAs.

The generic ingredient in GEN-XENE is clorazepate dipotassium. There are eight drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the clorazepate dipotassium profile page.
Summary for GEN-XENE
Drug patent expirations by year for GEN-XENE
Medical Subject Heading (MeSH) Categories for GEN-XENE
Synonyms for GEN-XENE
(Chloromethyl)(dimethyl)(tridecyloxy)silane
149128-44-9
1H-1,4-Benzodiazepine-3-carboxylic acid, 7-chloro-2,3-dihydro-2-oxo-5-phenyl-
1H-1,4-Benzodiazepine-3-carboxylic acid, 7-chloro-2,3-dihydro-2-oxo-5-phenyl-, monopotassium salt, compd. with potassium hydroxide
1H-1,4-Benzodiazepine-3-carboxylic acid, 7-chloro-2,3-dihydro-2-oxo-5-phenyl-, monopotassium salt, compd. with potassium hydroxide (K(OH)) (1:1)
1H-1,4-Benzodiazepine-3-carboxylic acid, 7-chloro-2,3-dihydro-2-oxo-5-phenyl-, potassium salt compd. with potassium hydroxide (1:1)
1H-1,4-Benzodiazepine-3-carboxylic acid, 7-chloro-2,3-dihydro-2-oxo-5-phenyl-, potassium salt compound with potassium hydroxide (1:1)
1H-1,4-Benzodiazepine-3-carboxylic acid, 7-chloro-2,3-dihydro-2-oxo-5-phenyl-,monopotassium salt, compd. with potassium hydroxide
1H-1,4-Benzodiazepine-3-carboxylicacid, 7-chloro-2,3-dihydro-2-oxo-5-phenyl-, (-)-
20432-69-3
23887-31-2
27665-58-3
28425-34-5
4306 CB
4306-CB
57109-90-7
7-chloro-2-oxo-5-phenyl-1,3-dihydro-1,4-benzodiazepine-3-carboxylic acid
7-chloro-2-oxo-5-phenyl-2,3-dihydro-1H-1,4-benzodiazepine-3-carboxylic acid
7-chloro-2,3-dihydro-2-oxo-5-phenyl-1H-1,4-benzodiazepine-3-carboxylic acid
7-Chloro-2,3-dihydro-2,2-dihydroxy-5-phenyl-1H-1,4-benzodiazepine-3-carboxylic acid
AB 35616
Abbott-35616
AC1L1EIN
AC1Q3S8C
ACMC-20dcfi
AH 3232
Belseren
Bipotassium chlorazepate
C06921
C16H10ClN2O3.HKO.K
CB 4306
Cchlorazepic acid
CHEBI:3761
CHEBI:3762
CHEMBL1213252
CHEMBL2096631
Chlorazepam
Chlorazepate
Chlorazepate dipotassium
Chlorazepic acid
clorazepate
Clorazepate acid dipotassium salt
Clorazepate dipotassique
Clorazepate dipotassique [INN-French]
Clorazepate dipotassium
Clorazepate dipotassium (JP17/USP)
Clorazepate Dipotassium [USAN:JAN]
Clorazepate dipotassium [USAN:USP:JAN]
clorazepate potassium
Clorazepato
Clorazepato [DCIT]
Clorazepato dipotasico
Clorazepato dipotasico [INN-Spanish]
Clorazepic acid
Clorazepic acid [BAN]
CTK0H0237
D00694
D0P3JU
DB00628
DEA No. 2768
Dikalii clorazepas
Dikalii clorazepas [INN-Latin]
Dipotassium chlorazepate
Dipotassium clorazepate
Dipotassium clorazepate [INN]
EINECS 245-926-8
EINECS 260-565-6
GTPL7548
HE061147
HE274088
HE327718
HSDB 3041
LS-182361
LS-187760
LS-34023
Mendon
Modiur
Nevracten
Novo-Clopate
Novo-Clopate (TN)
Potassium 7-chloro-2,3-dihydro-2-oxo-5-phenyl-1H-1,4-benzodiazepine-3-carboxylate compound with potassium hydroxide (1:1)
Potassium 7-chloro-2,3-dihydro-2-oxo-5-phenyl-1H-1,4-benzodiazepine-3-carboxylate KOH
Potassium Clorazepate
QCHSEDTUUKDTIG-UHFFFAOYSA-L
SCHEMBL1649064
Softramal
Tencilan
TR 19119
Transilium
Tranxene
Tranxene (Cherazepate dipotasium)
Tranxene (TN)
Tranxene /Cherazepate dipotasium/
TRANXENE SD
Tranxene®
Tranxilen
Tranxilene
Tranxilium
XDDJGVMJFWAHJX-UHFFFAOYSA-N

US Patents and Regulatory Information for GEN-XENE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Alra GEN-XENE clorazepate dipotassium TABLET;ORAL 071787-001 Apr 26, 1988 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Alra GEN-XENE clorazepate dipotassium TABLET;ORAL 071788-001 Apr 26, 1988 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Alra GEN-XENE clorazepate dipotassium TABLET;ORAL 071789-001 Apr 26, 1988 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fish and Richardson
Accenture
Boehringer Ingelheim
Moodys
Cantor Fitzgerald
Deloitte
Cipla
Medtronic
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.